Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Capital Leases (2024 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Capital Leases for 2 consecutive years, with $11000.0 as the latest value for Q1 2025.

  • For Q1 2025, Capital Leases changed N/A year-over-year to $11000.0; the TTM value through Mar 2025 reached $11000.0, changed N/A, while the annual FY2024 figure was $44000.0, N/A changed from the prior year.
  • Capital Leases hit $11000.0 in Q1 2025 for Artiva Biotherapeutics, down from $44000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $106000.0 in Q2 2024 and bottomed at $11000.0 in Q1 2025.